ARCHIVES

Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014

DCT Board Okays New Surgery RFA, Will Hear Request For Support Of 30 Surgical Centers

April 11, 1980

2015 Goal Not a Dream, But a Vision, Director Says

July 18, 2003

Obama Executive Order Gives FDA Authority To Combat Drug Shortages

November 4, 2011

Educational Strategies On Mammography, Not Guidelines, To Come From NCAB

February 28, 1997

AACR Using Its Clout To Urge Higher NCI Budget

May 24, 1991